Hans?Peter Brunner?La Rocca
AuthID: R-00J-ZJM
1
TÃTULO: Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial Full Text
AUTORES: Pierpaolo Pellicori; João Pedro Ferreira ; Beatrice Mariottoni; Hans‐Peter Brunner‐La Rocca; Fozia Z Ahmed; Job Verdonschot; Tim Collier; Joe J Cuthbert; Johannes Petutschnigg; Blerim Mujaj; Nicolas Girerd; Arantxa González; Andrew L Clark; Franco Cosmi; Jan A Staessen; Stephane Heymans; Roberto Latini; Patrick Rossignol; Faiez Zannad; John G.F Cleland;
PUBLICAÇÃO: 2020, FONTE: European Journal of Heart Failure, VOLUME: 22, NÚMERO: 9
AUTORES: Pierpaolo Pellicori; João Pedro Ferreira ; Beatrice Mariottoni; Hans‐Peter Brunner‐La Rocca; Fozia Z Ahmed; Job Verdonschot; Tim Collier; Joe J Cuthbert; Johannes Petutschnigg; Blerim Mujaj; Nicolas Girerd; Arantxa González; Andrew L Clark; Franco Cosmi; Jan A Staessen; Stephane Heymans; Roberto Latini; Patrick Rossignol; Faiez Zannad; John G.F Cleland;
PUBLICAÇÃO: 2020, FONTE: European Journal of Heart Failure, VOLUME: 22, NÚMERO: 9
